Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$2B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$109M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Townsend Richard Nolan | Nov 18, 2025 | Sell | 1,127 | $9.27 | $10,000 |
| See Tai Sandi | Nov 18, 2025 | Sell | 386 | $9.27 | $3,600 |
| Robertson Jenny | Nov 18, 2025 | Sell | 549 | $9.27 | $5,100 |
| Adler Eric | Nov 18, 2025 | Sell | 615 | $9.27 | $5,700 |
| Townsend Richard Nolan | Oct 17, 2025 | Sell | 12,985 | $8.935 | $120,000 |
| Otero Jose Manuel | Oct 17, 2025 | Sell | 2,091 | $8.935 | $19,000 |
| See Tai Sandi | Oct 17, 2025 | Sell | 3,844 | $8.935 | $34,000 |
| Robertson Jenny | Oct 17, 2025 | Sell | 3,486 | $8.935 | $31,000 |
| Adler Eric | Oct 17, 2025 | Sell | 3,344 | $8.935 | $30,000 |
| Townsend Richard Nolan | Oct 17, 2025 | Sell | 148 | $9.561 | $1,400 |
| Otero Jose Manuel | Oct 17, 2025 | Sell | 24 | $9.561 | $230 |
| See Tai Sandi | Oct 17, 2025 | Sell | 44 | $9.561 | $420 |
| Robertson Jenny | Oct 17, 2025 | Sell | 40 | $9.561 | $380 |
| Adler Eric | Oct 17, 2025 | Sell | 38 | $9.561 | $360 |
| Townsend Richard Nolan | Aug 18, 2025 | Sell | 1,115 | $4.668 | $5,200 |
| Otero Jose Manuel | Aug 18, 2025 | Sell | 2,848 | $4.668 | $13,000 |
| Townsend Richard Nolan | Aug 18, 2025 | Sell | 2,735 | $4.668 | $13,000 |
| Otero Jose Manuel | Aug 18, 2025 | Sell | 721 | $9.27 | $6,700 |
| Robertson Jenny | Aug 18, 2025 | Sell | 542 | $4.668 | $2,500 |
| Adler Eric | Aug 18, 2025 | Sell | 608 | $4.668 | $2,800 |
| See Tai Sandi | Aug 18, 2025 | Sell | 382 | $4.668 | $1,800 |
| Townsend Richard Nolan | May 16, 2025 | Sell | 1,074 | $2.774 | $3,000 |
| Adler Eric | May 16, 2025 | Sell | 585 | $2.774 | $1,600 |
| Robertson Jenny | May 16, 2025 | Sell | 521 | $2.774 | $1,400 |
| See Tai Sandi | May 16, 2025 | Sell | 367 | $2.774 | $1,000 |
| Townsend Richard Nolan | Feb 19, 2025 | Sell | 4,326 | $4.413 | $19,000 |
| See Tai Sandi | Feb 19, 2025 | Sell | 1,486 | $4.413 | $6,600 |
| Adler Eric | Feb 19, 2025 | Sell | 2,359 | $4.413 | $10,000 |
| Robertson Jenny | Feb 19, 2025 | Sell | 2,101 | $4.413 | $9,300 |
| Townsend Richard Nolan | Dec 10, 2024 | Sell | 2,500 | $8.1965 | $20,000 |
| CHOLMONDELEY PAULA H | Nov 25, 2024 | Buy | 15,000 | $6.9901 | $100,000 |
| Townsend Richard Nolan | Nov 11, 2024 | Sell | 2,500 | $7.8227 | $20,000 |
| Townsend Richard Nolan | Oct 10, 2024 | Sell | 5,000 | $8.0991 | $40,000 |
| Townsend Richard Nolan | Sep 10, 2024 | Sell | 5,000 | $10.6547 | $53,000 |
| Townsend Richard Nolan | Aug 12, 2024 | Sell | 5,000 | $11.5269 | $58,000 |
| Townsend Richard Nolan | Jul 11, 2024 | Sell | 27,931 | $17.06 | $480,000 |
| Townsend Richard Nolan | Jul 11, 2024 | Sell | 100 | $19.06 | $1,900 |
| Townsend Richard Nolan | Jul 10, 2024 | Sell | 23,622 | $16.45 | $390,000 |
| Townsend Richard Nolan | Jul 10, 2024 | Sell | 3,347 | $16.85 | $56,000 |
| Townsend Richard Nolan | Jun 10, 2024 | Sell | 2,962 | $17.29 | $51,000 |
| Townsend Richard Nolan | Jun 10, 2024 | Sell | 2,038 | $18.18 | $37,000 |
| Townsend Richard Nolan | May 13, 2024 | Sell | 5,000 | $13.2186 | $66,000 |
FAQ - Insider Transactions
The most recent insider transaction for Lexeo Therapeutics was conducted by Townsend Richard Nolan, who sold 1,127 shares on November 18, 2025 at a price of $9.27 per share.
CHOLMONDELEY PAULA H has bought the most LXEO stock in the last 2 years, with a total value of $100,000.
Townsend Richard Nolan has sold the most LXEO stock in the last 2 years, with a total value of $1.4M.
The total value of insider transactions for Lexeo Therapeutics in the last 2 years is negative, amounting to -$1.5M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Lexeo Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
